丑别补濒迟丑艑尘别 and Hannover Re Win 2024 Global Innovation Award for Genomics-Based Insurance Program
丑别补濒迟丑艑尘别 and Hannover Re have won the 2024 Global Innovation Award in the Life | Health | Retirement category for their genomics-based insurance program. The award, presented by the International Insurance Society, Insurance Thought Leadership, and Lloyd's, recognizes their successful integration of genomics-based services into critical illness and life insurance products.
The program, distributed through Chubb Workplace Benefits as Cancer Advocate Plus, provides employees with DNA-based precision health insights, personalized medication optimization, and cancer management support. In 2025, the service will be available to individuals outside the workplace as Kadance Precision Health Management Program.
丑别补濒迟丑艑尘别 e Hannover Re hanno vinto il Premio Globale per l'Innovazione 2024 nella categoria Vita | Salute | Previdenza per il loro programma assicurativo basato sulla genomica. Il premio, conferito dalla International Insurance Society, Insurance Thought Leadership e Lloyd's, riconosce la loro integrazione riuscita di servizi basati sulla genomica nei prodotti assicurativi per malattie gravi e vita.
Il programma, distribuito attraverso Chubb Workplace Benefits come Cancer Advocate Plus, fornisce ai dipendenti approfondimenti sulla salute di precisione basati sul DNA, ottimizzazione personalizzata dei medicinali e supporto nella gestione del cancro. Nel 2025, il servizio sar脿 disponibile per le persone al di fuori del posto di lavoro come Kadance Precision Health Management Program.
丑别补濒迟丑艑尘别 y Hannover Re han ganado el Premio Global de Innovaci贸n 2024 en la categor铆a de Vida | Salud | Jubilaci贸n por su programa de seguros basado en gen贸mica. El premio, presentado por la International Insurance Society, Insurance Thought Leadership y Lloyd's, reconoce su exitosa integraci贸n de servicios basados en gen贸mica en productos de seguros de enfermedades cr铆ticas y vida.
El programa, distribuido a trav茅s de Chubb Workplace Benefits como Cancer Advocate Plus, proporciona a los empleados informaci贸n de salud de precisi贸n basada en ADN, optimizaci贸n personalizada de medicamentos y apoyo en la gesti贸n del c谩ncer. En 2025, el servicio estar谩 disponible para individuos fuera del lugar de trabajo como Kadance Precision Health Management Program.
丑别补濒迟丑艑尘别鞕赌 Hannover Re臧 2024雲 旮搿滊矊 順侅嫚靸侅潉 靸濍獏 | 瓯搓皶 | 鞚韲 攵氍胳棎靹 鞙犾爠觳 旮半皹 氤错棙 頂勲攴鸽灗鞙茧 靾橃儊頄堨姷雼堧嫟. 鞚 靸侅潃 甑牅 氤错棙 順戫殞, 氤错棙 靷碃 毽崝鞁 氚 搿滌澊霌滌棎 鞚橅暣 靾橃棳霅橂┌, 欷戩 歆堧硲 氚 靸濍獏 氤错棙 靸來拡鞐 鞙犾爠觳 旮半皹 靹滊箘鞀るゼ 靹标车鞝侅溂搿 韱淀暕頃 瓴冹潉 鞚胳爼氚涭晿鞀惦媹雼.
鞚 頂勲攴鸽灗鞚 Chubb Workplace Benefits毳 韱淀暣 Cancer Advocate Plus搿 氚绊彫霅橂┌, 歆侅洂霌れ棎瓴 DNA 旮半皹鞚 鞝曤皜 瓯搓皶 韱奠鞍霠, 臧滌澑 毵烄钉順 鞎诫 斓滌爜頇 氚 鞎 甏毽 歆鞗愳潉 鞝滉车頃╇媹雼. 2025雲勲秬韯半姅 Kadance Precision Health Management Program鞙茧 歆侅灔 鞕 臧滌澑鞐愱矊霃 鞝滉车霅 鞓堨爼鞛呺媹雼.
丑别补濒迟丑艑尘别 et Hannover Re ont remport茅 le Prix Mondial de l'Innovation 2024 dans la cat茅gorie Vie | Sant茅 | Retraite pour leur programme d'assurance bas茅 sur la g茅nomique. Le prix, pr茅sent茅 par la Soci茅t茅 Internationale des Assurances, Insurance Thought Leadership et Lloyd's, reconna卯t leur int茅gration r茅ussie des services bas茅s sur la g茅nomique dans les produits d'assurance de maladies graves et vie.
Le programme, distribu茅 par Chubb Workplace Benefits sous le nom de Cancer Advocate Plus, offre aux employ茅s des informations de sant茅 de pr茅cision bas茅es sur l'ADN, une optimisation personnalis茅e des m茅dicaments et un soutien 脿 la gestion du cancer. En 2025, le service sera disponible pour les personnes en dehors du milieu de travail sous le nom de Kadance Precision Health Management Program.
丑别补濒迟丑艑尘别 und Hannover Re haben den Global Innovation Award 2024 in der Kategorie Leben | Gesundheit | Ruhestand f眉r ihr geneomik-basiertes Versicherungsprogramm gewonnen. Der Preis, der von der International Insurance Society, Insurance Thought Leadership und Lloyd's verliehen wird, w眉rdigt die erfolgreiche Integration genomik-basierter Dienstleistungen in Produkte f眉r kritische Krankheiten und Lebensversicherungen.
Das Programm, das 眉ber Chubb Workplace Benefits als Cancer Advocate Plus vertrieben wird, bietet den Mitarbeitern DNA-basierte pr盲zise Gesundheitsinformationen, personalisierte Medikamentenoptimierung und Unterst眉tzung im Umgang mit Krebs. Im Jahr 2025 wird der Service auch f眉r Personen au脽erhalb des Arbeitsplatzes als Kadance Precision Health Management Program verf眉gbar sein.
- Partnership with major insurers Hannover Re and Chubb expands market reach
- Recognition through prestigious industry award validates business model
- Planned expansion to individual market in 2025 opens new revenue streams
- Integration of genomics into insurance products creates competitive advantage
- None.
Award honors the integration of genomics into critical illness coverage, enhancing the value of life and critical illness products for insurers and policyholders.
"Receiving the 2024 Global Innovation Award is a testament to 丑别补濒迟丑艑尘别's dedication to advancing personalized, genomics-driven healthcare," said Darren Rowe, CEO of 丑别补濒迟丑艑尘别. "The support from Hannover Re, our reinsurer, and Chubb, our exclusive distribution partner in the worksite, has been vital in providing solutions that prioritize a proactive approach to health-first insurance-based programs that reshape how the industry serves members."
This award acknowledges the notable impact of 丑别补濒迟丑艑尘别's precision health management program. With support from Hannover Re, 丑别补濒迟丑艑尘别 successfully integrated genomics-based services into critical illness and life insurance, delivering an innovative solution to the personal insurance market. This collaboration demonstrates how 丑别补濒迟丑艑尘别 and Hannover Re empower insurers to push boundaries, improve product offerings, and enhance member engagement. By providing groundbreaking living benefit solutions, they also strengthen policyholder relationships, improve brand equity for insurance carriers, and drive better policy persistency, creating lasting value for insurers and their customers.
"We're thrilled to receive this prestigious award, in collaboration with our partner 丑别补濒迟丑艑尘别, that recognizes our commitment to advancing medical care for the treatment of cancer patients," said, Executive Vice President, Head of Health Solutions and General Counsel at Hannover Life Reassurance Company of America. "This partnership allows us to leverage genomic-based technologies and life insurance solutions to enhance patient care and support individuals in living longer, healthier lives."
In partnership with Chubb, 丑别补濒迟丑艑尘别's innovative services are distributed through 听as Cancer Advocate Plus. 丑别补濒迟丑艑尘别 provides听employees access to proactive, DNA-based precision health insights, a personalized medication optimization plan, and tailored cancer management support. Pairing these services provided by 丑别补濒迟丑艑尘别 with the insurance benefits offered by Chubb, Cancer Advocate Plus is redefining insurance with health-first solutions.
"This benefits partnership exemplifies our focus on innovating and delivering value for our customers," said Alex Faynberg, Division President, Chubb Workplace Benefits. "It's a proactive and personalized approach to combining precision health insights with cancer management support. And we are honored to offer this program to our broker partners and clients."
The recognition by the IIS underscores the significant strides made by 丑别补濒迟丑艑尘别 and its partners in integrating advanced genomics into insurance products, delivering enhanced value, and enabling personalized care for policyholders. In 2025, the product will also be available for individuals to purchase outside the workplace as , further expanding access to precision health and highlighting a shared commitment to driving innovation and excellence in insurance and healthcare.
About 丑别补濒迟丑艑尘别, Inc.
丑别补濒迟丑艑尘别, Inc. is a genomics-based, precision health navigation company operating at the intersection of life insurance, life science, and health management. With a fully integrated, in-house genetics lab, 丑别补濒迟丑艑尘别 is dedicated to simplifying and accelerating access to technologies and services that can dramatically alter an individual's health trajectory, with an initial focus on cancer. 丑别补濒迟丑艑尘别 designs and delivers tech-enabled, precision health management solutions through a network of life and critical insurance carriers. 丑别补濒迟丑艑尘别 and its subsidiary, , are based at the 听in
About Hannover Re
听is one of the world's leading reinsurers. It transacts all lines of property and casualty and life and health reinsurance and is present worldwide with more than 3,500 staff. German business of the Hannover Re Group is written by the subsidiary E+S R眉ck. Established in 1966, Hannover Re is recognized as a reliable partner for innovative risk solutions, exceptional customer intimacy and financial soundness. The rating agencies most relevant to the insurance industry have awarded both Hannover Re and E+S R眉ck outstanding financial strength ratings: Standard & Poor's AA- "Very Strong" and A.M. Best A+ "Superior".
About Chubb
Chubb is a world leader in insurance. With operations in 54 countries and territories, Chubb provides commercial and personal property and casualty insurance, personal accident and supplemental health insurance, reinsurance and life insurance to a diverse group of clients. The company is defined by its extensive product and service offerings, broad distribution capabilities, exceptional financial strength and local operations globally. Parent company Chubb Limited is listed on the New York Stock Exchange (NYSE: CB) and is a component of the S&P 500 index. Chubb employs approximately 40,000 people worldwide. Additional information can be found at: .
View original content:
SOURCE 丑别补濒迟丑艑尘别, Inc.
FAQ
What award did 丑别补濒迟丑艑尘别 and Hannover Re win in 2024?
When will 丑别补濒迟丑艑尘别's Kadance Precision Health Management Program launch for individual customers?